Mycobacterium chimaera as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards
ANNA T. ZABOST
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Perfil de OrcidBuscar este autor en
, , SYLWIA A. BRZEZIŃSKA
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Perfil de OrcidBuscar este autor en
, MAGDALENA D. KLATT
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Perfil de OrcidBuscar este autor en
y EWA M. AUGUSTYNOWICZ-KOPEĆ
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Perfil de OrcidBuscar este autor en
17 sept 2021
Acerca de este artículo
Categoría del artículo: original-paper
Publicado en línea: 17 sept 2021
Páginas: 315 - 320
Recibido: 31 mar 2021
Aceptado: 08 jul 2021
DOI: https://doi.org/10.33073/pjm-2021-028
Palabras clave
© 2021 Anna T. Zabost et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Fig. 1.
Pathogenicity of isolated M_ chimaera strains depending on sex, age, and concomitant pulmonary disease_
| NTMLD | Colonization | Total | ||
|---|---|---|---|---|
| Sex | ||||
| Men | 8 (50) | 8 (50) | 16(100) | |
| Women | 8 (57) | 6(43) | 14(100) | 0,86 |
| Age | ||||
| Years (mean+/-SD) | 58,3 (16,77) | 62,1 (12,86) | 60,1 (15,19) | 0,72 |
| Diagnosis | ||||
| Previous tuberculosis | 5 (83) | 1 (17) | 6 (100) | |
| COPD | 3 (38) | 5 (62) | 8 (100) | |
| Cystic fibrosis | 2(100) | 0 | 2 (100) | |
| Interstitial lung diseases | 2 (40) | 3 (60) | 5 (100) | |
| Post-inflammatory lung fibrosis | 0 | 3 (100) | 3 (100) | |
| Bronchiectasis | 4(100) | 0 | 4(100) | |
| Neoplastic diseases | 1 (50) | 1 (50) | 2 (100) | |
| Diabetes mellitus | 1 (50) | 1 (50) | 2 (100) | |
| Others | 0 | 4 (100) | 4 (100) | |
| No concomitant disease | 2(100) | 0 | 2 (100) | |
Clinical characteristics of patients with positive M_ chimaera isolates_
| Concomitant diseases | Number (%) of patients with a given diagnosis | ||
|---|---|---|---|
| Men | Women | Total | |
| COPD | 7 (44) | 1 (7) | 8 (27) |
| Previous tuberculosis | 5 (31) | 1 (7) | 6 (20) |
| Interstitial lung disease | 5 (31) | 0 | 5 (17) |
| Cystic fibrosis | 0 | 2 (14) | 2 (7) |
| Post-inflammatory lung fibrosis | 1 (6) | 2 (14) | 3 (10) |
| Bronchiectasis | 1 (6) | 3 (21) | 4 (13) |
| Neoplastic disease | 2 (13) | 0 | 2 (7) |
| Diabetes mellitus | 1 (6) | 1 (7) | 2 (7) |
| Others | 0 | 4 (21) | 4 (13) |
| At least 2 diagnoses | 5 (31) | 2 (14) | 7 (23) |
| No concomitant disease | 1 (6) | 1 (7) | 2 (7) |